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ABSTRACT
The ORION (Outbreak Reports and Intervention studies Of Nosocomial Infection) guidelines were
recently published with the aim of raising methodological standards and the clarity of reporting of
intervention studies in hospital infection control. The guidelines provide advice on use of appropriate
statistical analysis techniques and the measures necessary to prevent bias, with the aim of ensuring
complete transparency in reports of such interventions, their epidemiological context and potential
confounders. CMI authors and reviewers should consider these helpful proposals when designing,
reporting and assessing intervention and outbreak studies. Use of these guidelines should contribute to
the construction of a solid evidence base for control of antimicrobial resistance and healthcare-associated
infection.
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The seemingly inexorable rise in the incidence of
healthcare-associated infection (HCAI) caused by
antimicrobial-resistant pathogens (ARPs) is chal-
lenging current control strategies. ARPs of major
global concern include methicillin-resistant
Staphylococccus aureus, ﬂuoroquinolone-resistant
Clostridium difﬁcile, vancomycin- and ampicillin-
resistant Enterococcus faecium, and multiresistant
strains of diverse Gram-negative bacilli, including
Klebsiella pneumoniae, Enterobacter spp., Pseudomo-
nas aeruginosa and Acinetobacter baumannii. This
problem is fuelled by the overuse of antibiotics,
which selects resistant bacterial strains, and by
transmission of these strains among patients via
the hands of healthcare personnel and, less
commonly, contaminated equipment or medica-
tion. Transfer of colonised patients among differ-
ent hospitals and countries has led to pandemic
spread of successful clones of ARPs [1], and HCAI
caused by ARPs is now recognised as a major
threat to patient safety that requires concerted
international action [2].
Hospital management and care providers face
increasing pressures to implement effective pre-
ventive strategies to protect patients against the
risk of HCAI. In sharp contrast with this legiti-
mate call for a sound professional response, what
is the actual situation in hospital practice? Wide
variations in infection control strategies exist
among countries, as indicated by international
surveys [3]. Furthermore, many countries have
developed their own sets of guidelines, which do
not meet the standards of evidence-based medi-
cine, and which, far too often, do not achieve wide
acceptance by healthcare professionals.
There are several reasons for the failure to
develop sound, scientiﬁcally-based policy. First,
the interplay of multiple factors contributing to
the acquisition of HCAI requires multifaceted
control approaches that are difﬁcult to evaluate.
Second, the marked ecological diversity among
hospitals threatens the external validity of ﬁnd-
ings from local intervention studies. Third, the
temporal variation of HCAI risk is related to the
transmission dynamics of microbial pathogens
and to ﬂuctuations in risk-factors in the exposed
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population; therefore, evaluation of the protective
efﬁcacy of control interventions requires speciﬁc
statistical approaches, e.g., time-series analysis
[4]. Finally, practical, as well as ethical, barriers
have limited the feasibility of conducting rando-
mised controlled trials in hospital epidemiology,
making the quasi-experimental design the most
robust approach available in many cases.
Randomised controlled trial methodology
has been carefully deﬁned by authoritative
guidelines, e.g., the CONSORT (Consolidated
Standards of Reporting Trials) statement [5]. The
CONSORT statement sought to ensure that the
methods used in randomised controlled trials
were reported with a level of transparency that
was sufﬁcient to allow editors and readers to
adequately assess the strengths and weaknesses
of every trial, as well as any potential sources of
bias. Following on from this achievement, a
multidisciplinary group of UK researchers with
experience in systematic reviews has recently
published the ORION (Outbreak Reports and
Intervention studies Of Nosocomial Infection)
guidelines [6], with the aim of raising the meth-
odological standards and the clarity of reporting
of intervention studies in hospital infection
control.
The ORION guidelines provide advice on the
measures that should be taken to prevent bias, as
well as guidance on the use of appropriate
techniques for statistical analysis. The authors
plead for complete transparency in the way in
which such intervention studies are reported, as
well as in describing the epidemiological context
in which they are implemented. Furthermore,
they recommend full description of potential
confounders likely to inﬂuence the incidence of
HCAI or ARPs. As an aid to investigators, grant
reviewers, authors and editors, the ORION guide-
lines include a checklist of key elements to be
considered when designing and reporting out-
break investigations and planned intervention
studies. As with CONSORT, the authors of the
ORION guidelines recognise that their publica-
tion is a ‘work in progress’, which will need
revision as the science of healthcare epidemiology
advances. A web-site is open to receive comments
from the scientiﬁc community, which may be
taken into consideration for future revisions, in
conjunction with an evaluation of the guidelines’
impact on future publications.
Application of the ORION guidelines should
contribute to an improvement in the quality
of future intervention trials in hospital epidemi-
ology, and should also strengthen the validity and
general applicability of published ﬁndings. It is to
be hoped that authors and reviewers for CMI will
consider these helpful proposals when designing,
reporting and assessing intervention and out-
break studies. More consistent and complete
reports will also enable more extensive and
informative meta-analyses of studies conducted
in different healthcare and epidemiological set-
tings. Importantly, improved comparison of out-
come data among studies should facilitate the
identiﬁcation of contextual factors that determine
the success or failure of interventions. Consider-
ationof theORIONguidelines in structuring future
publications should also facilitate the development
of online cumulative databases of outbreak reports
(e.g., http://www.outbreak-database.com), which
are valuable for consolidating knowledge of
mechanisms of nosocomial transmission of speciﬁc
pathogens. The beneﬁt of such a concerted effort
by researchers should ultimately result in the
development of a stronger evidence base for sound
infection control policies.
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